Edgewise Therapeutics, Inc. (EWTX)
33.84
+1.02
(+3.11%)
USD |
NASDAQ |
Apr 13, 16:00
33.82
-0.02
(-0.06%)
After-Hours: 20:00
Edgewise Therapeutics Cash from Investing (TTM) : -32.79M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Glaukos Corp. | -77.61M |
| Nuvalent, Inc. | -124.08M |
| Boston Scientific Corp. | -2.64B |
| Edwards Lifesciences Corp. | -946.60M |
| Eli Lilly & Co. | -10.97B |